Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Dermatology

Free Subscription 26.05.2025 5 Am J Dermatopathol 1 Ann Intern Med 5 BMC Cancer 6 Br J Dermatol 1 Cancer 2 Cancer Lett 2 Clin Dermatol 8 Clin Exp Dermatol 5 Cutis 6 Int J Dermatol 6 J Dermatol 5 J Invest Dermatol 1 J Laryngol Otol 1 Mycoses 2 Plast Reconstr Surg 7 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. BASRAI S, Cassarino DS
   A Solitary Fibrofolliculoma on the Back With a Nevus.
   Am J Dermatopathol. 2025;47:e68-e70.
   PubMed         Abstract available
   
   
2. MEHTA A, Bowling A, Gordon ER, Adeuyan O, et al
   Concomitant Squamous Cell Carcinoma and Mycosis Fungoides Within the Same Lesion: A Case Report and Literature Review.
   Am J Dermatopathol. 2025;47:472-476.
   PubMed         Abstract available
   
   
3. KUNZLER E, Enos C, Bohannon M, Walker A, et al
   The University of Florida Dermatopathology Experience With the Pigmented Lesion Assay.
   Am J Dermatopathol. 2025;47:468-471.
   PubMed         Abstract available
   
   
4. CAZZATO G, Ingravallo G, Vitiello P, Pagliuca F, et al
   Unusual Nodule on the Left Leg of an Elderly Woman-A Case Report: Challenge.
   Am J Dermatopathol. 2025;47:e64-e66.
   PubMed         Abstract available
   
   
5. MURUGESU L, Tirumalae R
   Multicentric Reticulohistiocytosis-Histopathologic Spectrum in Indian Patients.
   Am J Dermatopathol. 2025;47:428-432.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

6. BUCKLEY DI, Hsu F, Dana T, Blackie K, et al
   Health Care Delivery of Clinical Preventive Services for People With Disabilities : A Systematic Review.
   Ann Intern Med. 2025;178:671-686.
   PubMed         Abstract available
   
   

   
   BMC Cancer

7. ARPINO G, De Angelis C, Gerratana L, Lambertini M, et al
   Patient preferences for treatments in hormone receptor-positive/HER2-negative metastatic breast cancer in Italy: a discrete choice experiment study.
   BMC Cancer. 2025;25:920.
   PubMed         Abstract available
   
   
8. NDLOVU AK, Kasvosve I, Rantshabeng PS, Sharma K, et al
   Female breast cancer classification using immunohistochemistry biomarkers staining in Botswana.
   BMC Cancer. 2025;25:893.
   PubMed         Abstract available
   
   
9. LI H, Zhang CT, Shao HG, Pan L, et al
   Prediction models of breast cancer molecular subtypes based on multimodal ultrasound and clinical features.
   BMC Cancer. 2025;25:886.
   PubMed         Abstract available
   
   
10. MOVAHED F, Dehbozorgi M, Goodarzi S, Abianeh FE, et al
    Effect of breast cancer surgery on levels of depression and anxiety: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:889.
    PubMed         Abstract available
    
    
11. ABD EL-KAREAM SA, Hassan NAM, Saleh HSA, Albahloul MAS, et al
    Microwave assisted drug delivery of titanium dioxide/rose Bengal conjugated chitosan nanoparticles for micro-photodynamic skin cancer treatment in vitro and in vivo.
    BMC Cancer. 2025;25:896.
    PubMed         Abstract available
    
    

    
    Br J Dermatol

12. GARGIULO L, Costanzo A
    Age of Onset Matters: Tildrakizumab Response in Early vs Late-Onset Psoriasis.
    Br J Dermatol. 2025 May 23:ljaf186. doi: 10.1093.
    PubMed        
    
    
13. DIMITRION PM, Krevh R, Veenstra J, Ge J, et al
    High-throughput proteomics identifies inflammatory proteins associated with disease severity and genetic ancestry in patients with hidradenitis suppurativa.
    Br J Dermatol. 2025;192:1063-1071.
    PubMed         Abstract available
    
    
14. APFELBACHER C, Bewley A, Molin S, Fargnoli MC, et al
    Prevalence of chronic hand eczema in adults: a cross-sectional survey of over 60 000 respondents from the general population of Canada, France, Germany, Italy, Spain and the UK.
    Br J Dermatol. 2025;192:1047-1054.
    PubMed         Abstract available
    
    
15. MURRELL DF, Bodemer C, Bruckner AL, Cunningham T, et al
    Long-term safety and efficacy of Oleogel-S10 (birch bark extract) in epidermolysis bullosa: 24-month results from the phase III EASE study.
    Br J Dermatol. 2025;192:1007-1017.
    PubMed         Abstract available
    
    
16. KIM BR, Kim G, Jin SP, Choi CW, et al
    Causal association between polyunsaturated fatty acids and acne: a two-sample Mendelian randomization study.
    Br J Dermatol. 2025;192:1106-1114.
    PubMed         Abstract available
    
    
17. MAHO-VAILLANT M, Lemieux A, Arnoult C, Lebourgeois L, et al
    Prevalence and pathogenic activity of anti-desmocollin-3 antibodies in patients with pemphigus vulgaris and pemphigus foliaceus.
    Br J Dermatol. 2025;192:1072-1082.
    PubMed         Abstract available
    
    

    
    Cancer

18. GARG SK, Kohli K, Garg IK, Garg YK, et al
    Disparities in receipt of palliative-intent treatment among disaggregated Hispanic populations with breast, lung, and prostate cancer in the United States.
    Cancer. 2025;131:e35903.
    PubMed         Abstract available
    
    

    
    Cancer Lett

19. GRIMSLEY HE, Antczak M, Reddin IG, Weiler N, et al
    Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkers.
    Cancer Lett. 2025 Apr 27:217754. doi: 10.1016/j.canlet.2025.217754.
    PubMed         Abstract available
    
    
20. XIE Y, Xie J, Huang G, Zhang J, et al
    Isoliquiritigenin reduces brain metastasis by circNAV3-ST6GALNAC5-EGFR axis in triple negative breast cancer.
    Cancer Lett. 2025 Apr 21:217734. doi: 10.1016/j.canlet.2025.217734.
    PubMed         Abstract available
    
    

    
    Clin Dermatol

21. WALTER S
    The portrayal of moles in dermatology cartoons.
    Clin Dermatol. 2025;43:427-430.
    PubMed         Abstract available
    
    
22. WOLLINA U, Hoenig LJ, Walter S, Parish LC, et al
    The church spire sign.
    Clin Dermatol. 2025;43:423-426.
    PubMed         Abstract available
    
    

    
    Clin Exp Dermatol

23. BOWE S, Murphy M, Bourke J, Ryan C, et al
    Prescribing Practices Among Psoriasis Experts for Patients with Concomitant Malignancy: A Survey of International Psoriasis Council Members.
    Clin Exp Dermatol. 2025 May 20:llaf198. doi: 10.1093.
    PubMed         Abstract available
    
    
24. ALABAS OA, Evans I, Mcelhone K, Yiu ZZN, et al
    Evaluating changes in baseline characteristics and drug utilisation pattern in patients with moderate-to-severe psoriasis: findings from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) Cohort.
    Clin Exp Dermatol. 2025 May 22:llaf224. doi: 10.1093.
    PubMed         Abstract available
    
    
25. CHEN Y, Sun S, Yang H, Fei X, et al
    Global prevalence of mental health comorbidity in patients with acne: an analysis of trends from 1961 to 2023.
    Clin Exp Dermatol. 2025;50:1083-1093.
    PubMed         Abstract available
    
    
26. BETTUZZI T, Lebrun-Vignes B, Assier H, Pina Vegas L, et al
    Recurrences and rechallenges of suspected drugs in patients with epidermal necrolysis.
    Clin Exp Dermatol. 2025;50:1116-1124.
    PubMed         Abstract available
    
    
27. ZABIHI H, Maliyar K, Sibbald C, Verstegen RHJ, et al
    Outcomes of ciclosporin treatment in paediatric patients with drug reaction with eosinophilia and systemic symptoms (DRESS): a retrospective cohort analysis.
    Clin Exp Dermatol. 2025;50:1183-1187.
    PubMed         Abstract available
    
    
28. BYRNES KG, Flowers RH
    Tuberculosis screening in patients with hidradenitis suppurativa on tumour necrosis factor inhibitors: a retrospective chart review.
    Clin Exp Dermatol. 2025;50:1193-1195.
    PubMed         Abstract available
    
    
29. MELLERIO JE, Pillay EI, Sollesta K, Thiel KE, et al
    Milestone events in recessive dystrophic epidermolysis bullosa: findings of the PEBLES study.
    Clin Exp Dermatol. 2025;50:1125-1131.
    PubMed         Abstract available
    
    
30. WANG QX, He HY, Niu YL, Fang S, et al
    Refractory eosinophilic pustular folliculitis treated with tofacitinib: a case series and literature review.
    Clin Exp Dermatol. 2025;50:1196-1200.
    PubMed         Abstract available
    
    

    
    Cutis

31. OSBORNE S, Kam O, Wescott R, Thacker S, et al
    Exploring the Relationship Between Psoriasis and Mobility Among US Adults.
    Cutis. 2025;115:E14-E17.
    PubMed        
    
    
32. SEQUEIRA MJ, Ballestas NP, Sequeira EM
    Managing Cutaneous Reactions to Yellow Fly (Diachlorus ferrugatus) Bites.
    Cutis. 2025;115:121-124.
    PubMed         Abstract available
    
    
33. WELCH D, Usatine RP, Heath CR
    Beyond the Razor: Managing Pseudofolliculitis Barbae in Skin of Color.
    Cutis. 2025;115:135-136.
    PubMed        
    
    
34. SEBASTIAO E, Patton E
    Using Superficial Curettage to Diagnose Talon Noir.
    Cutis. 2025;115:133-134.
    PubMed         Abstract available
    
    
35. ZEMLOK SK, Choi S, Atwater AR, Reeder MJ, et al
    Simplifying Allergic Contact Dermatitis Management with the Contact Allergen Management Program 2.0.
    Cutis. 2025;115:111-115.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

36. LIU Y, Wang X
    Linear Immunoglobulin A/G Bullous Dermatosis With Dual Autoimmunity to BP230 and Type VII Collagen.
    Int J Dermatol. 2025 May 19. doi: 10.1111/ijd.17859.
    PubMed        
    
    
37. BARTOSINSKA J, Szepietowski JC, Raczkiewicz D, Griffiths CEM, et al
    Epidemiology of Psoriasis in Poland: Prevalence, Incidence, and Mortality Rates.
    Int J Dermatol. 2025 May 19. doi: 10.1111/ijd.17848.
    PubMed         Abstract available
    
    
38. KASSELS AC, Arora JS, Kraus CN
    Lichen Sclerosus Is Associated With Atopic Conditions: A Retrospective Population-Level Study.
    Int J Dermatol. 2025 May 20. doi: 10.1111/ijd.17854.
    PubMed        
    
    
39. COLE-ADEIFE O, Khoza N, Otrofanowei E, Anaba E, et al
    Skincare Practices and Concerns Among Social-Media Active African Adults: Insights From a Digital Survey.
    Int J Dermatol. 2025 May 20. doi: 10.1111/ijd.17860.
    PubMed        
    
    
40. BISWAS D, Bains A, Aggarwal D
    Subacute Cutaneous Lupus Erythematosus Triggered by Radiation Therapy.
    Int J Dermatol. 2025 May 20. doi: 10.1111/ijd.17865.
    PubMed        
    
    
41. GANTZ HY, Yi RC, Ruley AJ, Mukenge MM, et al
    Challenging the Dogma That Psoriasis Skin Lesions Occur Before Arthritis.
    Int J Dermatol. 2025 May 21. doi: 10.1111/ijd.17862.
    PubMed         Abstract available
    
    

    
    J Dermatol

42. YAMAZAKI K, Tomita K, Masuda Y, Yagi H, et al
    Successful Treatment of Both Cutaneous and Extracutaneous Lesions in Systemic Sarcoidosis With Tranilast.
    J Dermatol. 2025 May 23. doi: 10.1111/1346-8138.17765.
    PubMed        
    
    
43. LIU Y, He H, Zhang C, Pan W, et al
    A Wool Hat-A Case of Scalp Psoriasis.
    J Dermatol. 2025 May 23. doi: 10.1111/1346-8138.17793.
    PubMed        
    
    
44. NAKANO E, Ogata D, Namikawa K, Yamazaki N, et al
    Real-World Efficacy and Safety of Anti-PD-1 Antibody Therapy for Patients With Advanced Cutaneous Squamous Cell Carcinoma: A Single-Center Retrospective Study in Japan.
    J Dermatol. 2025 May 23. doi: 10.1111/1346-8138.17799.
    PubMed         Abstract available
    
    
45. HIRANO S, Ikuno Y, Yamaguchi A, Takahashi T, et al
    Early-Stage Limited Cutaneous Systemic Sclerosis Successfully Treated With Guselkumab: Possibility of Early Intervention in the Pathogenesis.
    J Dermatol. 2025 May 22. doi: 10.1111/1346-8138.17796.
    PubMed        
    
    
46. CHARBEL N, Saade D, Maalouly M, Kreidieh F, et al
    Kaposi Sarcoma's Silent Symphony: An Atypical Auricular Presentation.
    J Dermatol. 2025 May 22. doi: 10.1111/1346-8138.17797.
    PubMed        
    
    
47. YATSUZUKA K, Muto J, Kohri N, Yoshida S, et al
    Complete Resolution of Residual Psoriasis by Adding Tapinarof Cream to Tildrakizumab: A Case Report.
    J Dermatol. 2025 May 20. doi: 10.1111/1346-8138.17792.
    PubMed        
    
    

    
    J Invest Dermatol

48. LECUMBERRI A, Berna-Rico E, Gelfand JM, Svedbom A, et al
    Residual Inflammation in Patients with Psoriasis Treated with Biologic Therapy: Findings from 3 Prospective Observational Cohorts.
    J Invest Dermatol. 2025 Apr 23:S0022-202X(25)00377.
    PubMed         Abstract available
    
    
49. PERES J, Damerell V, Chauhan J, Popovic A, et al
    Corrigendum to 'TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, which Prevents Activation of E-Cadherin by MITF' Journal of Investigative Dermatology, Volume 141, Issue 9, September 2021, Pages 2250-2260.
    J Invest Dermatol. 2025 May 21:S0022-202X(24)03018.
    PubMed        
    
    
50. ZHANG J, Yu Y, Zhao P, Yuan L, et al
    Clinical characteristics of hand eczema and its association with atopic dermatitis in the Chinese population: A multicenter cross-sectional study.
    J Invest Dermatol. 2025 May 19:S0022-202X(25)00486.
    PubMed         Abstract available
    
    
51. BAEZ E, Gyldenlove M, Ben Abdallah H, Emmanuel T, et al
    Oral roflumilast suppresses pro-inflammatory cytokine signaling and reduces CD4+ T cell and neutrophil infiltration in psoriasis.
    J Invest Dermatol. 2025 May 20:S0022-202X(25)00491.
    PubMed         Abstract available
    
    
52. CAMERA E, Di Nardo A
    A Microbial Shield: Interactions between UVR, cis-Urocanic Acid, and the Skin Microbiome.
    J Invest Dermatol. 2025 May 22:S0022-202X(25)00452.
    PubMed        
    
    

    
    J Laryngol Otol

53. BHARDWAJ A, Suji PS, Sood R, Malhotra M, et al
    Outcomes and symptom-specific quality of life after microscopic parotidectomy: a prospective study.
    J Laryngol Otol. 2025;139:304-310.
    PubMed         Abstract available
    
    

    
    Mycoses

54. LIPNER SR, Gupta AK, Joseph WS, Elewski B, et al
    Efficacy and Safety of Efinaconazole 10% Topical Solution for Treatment of Onychomycosis in Older Adults: A Post Hoc Analysis of Two Phase 3 Randomised Trials.
    Mycoses. 2025;68:e70069.
    PubMed         Abstract available
    
    

    
    Plast Reconstr Surg

55. AHMED S, Zaidi S, Fisher CS, Ludwig KK, et al
    Prophylactic Absorbable Antibiotic Beads: Effect on Tissue Expander Reconstruction Outcomes following Mastectomy Skin Necrosis.
    Plast Reconstr Surg. 2025 May 20. doi: 10.1097/PRS.0000000000012220.
    PubMed         Abstract available
    
    
56. BAE J, Lee JK, Lee KT
    Advancing Pure-Skin-Perforator Flap Application: Microscope-Free Harvesting, Versatile Donor Sites, and Clinical Outcomes.
    Plast Reconstr Surg. 2025 May 20. doi: 10.1097/PRS.0000000000012215.
    PubMed         Abstract available
    
    

    
    PLoS One

57. DANISH F
    A design-based framework for optimal stratification using super-population models with application on real data set of breast cancer.
    PLoS One. 2025;20:e0323619.
    PubMed         Abstract available
    
    
58. DINKEL Z, Baker A, Akins A, King KL, et al
    Collagen architecture in triple negative breast cancer.
    PLoS One. 2025;20:e0324655.
    PubMed         Abstract available
    
    
59. PUN Z, Xue Q, Zhang Y
    Enhancing ERalpha-targeted compound efficacy in breast cancer threapy with ExplainableAI and GeneticAlgorithm.
    PLoS One. 2025;20:e0319673.
    PubMed         Abstract available
    
    
60. EFAT AH
    Chi2 weighted ensemble: A multi-layer ensemble approach for skin lesion classification using a novel framework - optimized RegNet synergy with Attention-Triplet.
    PLoS One. 2025;20:e0321803.
    PubMed         Abstract available
    
    
61. FANG W, Tang S, Yan D, Dai X, et al
    Breast cancer pathology image recognition based on convolutional neural network.
    PLoS One. 2025;20:e0311728.
    PubMed         Abstract available
    
    
62. TOLSON H, Yamamoto RK, Kikuchi R, Sadrolashrafi K, et al
    Comparing antibiotic prescribing patterns for hidradenitis suppurativa between the emergency department and ambulatory care setting.
    PLoS One. 2025;20:e0310651.
    PubMed         Abstract available
    
    
63. HUA P, Tu Y, Yang Z, He Y, et al
    Minocycline inhibits rosacea-like inflammation through the TLR4-mediated NF-kappaB signaling pathway in vivo and in vitro.
    PLoS One. 2025;20:e0323598.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.